- Home
- GH vs VNOM Comparison
GH vs VNOM Comparison
Compare GH & VNOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- VNOM
- Stock Information
- Founded
- GH 2011
- VNOM 2013
- Country
- GH United States
- VNOM United States
- Employees
- GH N/A
- VNOM N/A
- Industry
- GH Medical Specialities
- VNOM Oil & Gas Production
- Sector
- GH Health Care
- VNOM Energy
- Exchange
- GH Nasdaq
- VNOM Nasdaq
- Market Cap
- GH 5.5B
- VNOM 4.9B
- IPO Year
- GH 2018
- VNOM 2014
- Fundamental
- Price
- GH $40.62
- VNOM $39.69
- Analyst Decision
- GH Strong Buy
- VNOM Strong Buy
- Analyst Count
- GH 21
- VNOM 13
- Target Price
- GH $52.81
- VNOM $55.00
- AVG Volume (30 Days)
- GH 2.3M
- VNOM 950.6K
- Earning Date
- GH 04-30-2025
- VNOM 05-05-2025
- Dividend Yield
- GH N/A
- VNOM 6.22%
- EPS Growth
- GH N/A
- VNOM 42.93
- EPS
- GH N/A
- VNOM 3.82
- Revenue
- GH $773,996,000.00
- VNOM $854,200,000.00
- Revenue This Year
- GH $23.05
- VNOM $50.64
- Revenue Next Year
- GH $21.40
- VNOM $21.69
- P/E Ratio
- GH N/A
- VNOM $10.38
- Revenue Growth
- GH 28.20
- VNOM 2.52
- 52 Week Low
- GH $20.14
- VNOM $34.71
- 52 Week High
- GH $52.92
- VNOM $56.76
- Technical
- Relative Strength Index (RSI)
- GH 48.45
- VNOM 43.58
- Support Level
- GH $37.73
- VNOM $39.41
- Resistance Level
- GH $39.63
- VNOM $40.70
- Average True Range (ATR)
- GH 1.60
- VNOM 0.90
- MACD
- GH -0.01
- VNOM -0.13
- Stochastic Oscillator
- GH 60.00
- VNOM 12.23
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About VNOM Viper Energy Inc.
Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.